Video Experimental Relacionado
Updated: Jun 22, 2025

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells
Published on: October 16, 2018
Los linfocitos como un medicamento vivo para el cáncer
1National Cancer Institute, Bethesda, MD, USA.
La terapia celular adoptiva utilizando los propios linfocitos del paciente está aprobada para el tratamiento del melanoma. Este enfoque de inmunoterapia es prometedor para aplicaciones clínicas más amplias que los usos actuales.
Área de la Ciencia:
- Inmunología
- En el campo de la oncología
Sus antecedentes:
- La terapia celular adoptiva (TCA) aprovecha las células inmunes derivadas del paciente.
- Los linfocitos, en particular los linfocitos que se infiltran en el tumor (TIL), son componentes clave de ACT.
Más Videos Relacionados
07:45Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8+ T Cells During LN Metastasis
Published on: January 26, 2024
07:55Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
Published on: January 17, 2025
Videos de Conceptos Relacionados
Tumor Immunotherapy
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...